Table 1.

Characteristics of 5 patients with PNH undergoing nonmyeloablative hematopoietic cell transplantation


Patient no.

Age, y

Sex

Disease duration, mo*

GPI-negative granulocytes, %

GPI-negative RBCs, %

Pretransplantation hemoglobin level, g/L

Pretransplantation platelet count, × 109/L

Indication for transplantation
1   30   M   15   92   64   92   43   RBC transfusion dependent, portal vein thrombosis  
2   25   F   31   97   45   77   154   RBC transfusion dependent, lower extremity DVT  
3   35   M   23   92   22   75   15   RBC transfusion dependent, pancytopenia  
4§  26   F   15   13   1.1   84   28   RBC and platelet transfusion dependent, pancytopenia  
5
 
35
 
M
 
49
 
92
 
36
 
82
 
36
 
Splenic vein thrombosis, pancytopenia
 

Patient no.

Age, y

Sex

Disease duration, mo*

GPI-negative granulocytes, %

GPI-negative RBCs, %

Pretransplantation hemoglobin level, g/L

Pretransplantation platelet count, × 109/L

Indication for transplantation
1   30   M   15   92   64   92   43   RBC transfusion dependent, portal vein thrombosis  
2   25   F   31   97   45   77   154   RBC transfusion dependent, lower extremity DVT  
3   35   M   23   92   22   75   15   RBC transfusion dependent, pancytopenia  
4§  26   F   15   13   1.1   84   28   RBC and platelet transfusion dependent, pancytopenia  
5
 
35
 
M
 
49
 
92
 
36
 
82
 
36
 
Splenic vein thrombosis, pancytopenia
 

DVT indicates deep vein thrombosis.

*

The duration from the diagnosis of PNH to transplantation.

The percentage of GPI-anchored protein-negative granulocytes prior to transplantation.

The percentage of GPI-anchored protein-negative red blood cells prior to transplantation.

§

Patient no. 4 had a diagnosis of aplastic anemia and PNH.

Close Modal

or Create an Account

Close Modal
Close Modal